Erik H.A.M. van Muilekom

The Netherlands Cancer Institute

Papers

2

Total Citations

40

H-Index

2

About

Erik H.A.M. van Muilekom is a clinical researcher focused on patient-reported outcomes and quality of life (QOL) following prostate cancer treatment, with a particular emphasis on surgical interventions. His major contributions center on refining how functional outcomes are measured after radical prostatectomy, demonstrating that interview-based assessments can be as reliable as extensive QOL questionnaires while being more practical for routine clinical use. His most cited work, "Interview-Based Versus Questionnaire-Based Quality of Life Outcomes Before and After Prostatectomy" (2013), has accumulated 32 citations and highlights the importance of balancing scientific rigor with clinical feasibility in capturing patient well-being. Additionally, his research on "Salvage Radiotherapy After Robot-assisted Laparoscopic Radical Prostatectomy" (2013) addresses critical treatment pathways for recurrence, contributing to the growing body of evidence on multimodal management of prostate cancer. Through these studies, van Muilekom has advanced the integration of patient-centered metrics into urological oncology, helping clinicians better understand and address the real-world impacts of treatment on patients' lives. His work remains valuable for researchers and practitioners seeking to optimize both the measurement and outcomes of prostate cancer care.

Research Focus

Key Achievements

2
H-Index
2
Papers
40
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Interview-Based Versus Questionnaire-Based Quality of Life Outcomes Before and After Prostatectomy
32 citations · 2013
📈 Most Prolific Year: 2013 (2 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: The Netherlands Cancer Institute

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago